Evidence map›Paper›PMID 38363132›Full record

ArticleMicrobiology spectrum2024

Drug-induced stress mediates

Lucien Platon, Didier Leroy, David A Fidock, Didier Ménard

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbiology spectrum, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
3.3field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Artemisinin-resistant malaria.Clinical microbiology reviews · 2024
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 3 countries.

Lucien PlatonMalaria Genetics and Resistance Unit, INSERM U1201, Institut Pasteur, Université Paris Cité, Paris, France.ORCID 0000-0001-7894-5977
Didier LeroyDepartment of Drug Discovery, Medicines for Malaria Venture, Geneva, Switzerland.
David A FidockDepartment of Microbiology and Immunology, Columbia University Irving Medical Center, New York, New York, USA.ORCID 0000-0001-6753-8938
Didier MénardMalaria Genetics and Resistance Unit, INSERM U1201, Institut Pasteur, Université Paris Cité, Paris, France.ORCID 0000-0003-1357-4495
Inserm · FRColumbia University Irving Medical Center · USMedicines for Malaria Venture · CH

Funding

Defining P. falciparum resistance to artemisinin-based combination therapiesR01AI109023 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI FIDOCK, DAVID A · 2014 to 2025
$4.4M
NIAID NIH HHS R01 AI109023
6 · The paper itself

Abstract

During blood-stage infection,

Indexed as

AntimalarialsArtemisininsMalaria, FalciparumParasitesAnimalsDrug ResistancePlasmodium falciparumProtozoan ProteinsAntimalarialsartemisininArtemisininsartenimolProtozoan Proteinsartemisinin resistanceintercellular communicationmalariaP. falciparumring stagestemporary cell growth arrest

Identifiers

PMID38363132
PMCPMC10986542
OpenAlexW4391884346

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.